000 | 01503 a2200409 4500 | ||
---|---|---|---|
005 | 20250512003958.0 | ||
264 | 0 | _c19900202 | |
008 | 199002s 0 0 eng d | ||
022 | _a0031-6970 | ||
024 | 7 |
_a10.1007/BF00558494 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPicca, M | |
245 | 0 | 0 |
_aComparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris. _h[electronic resource] |
260 |
_bEuropean journal of clinical pharmacology _c1989 |
||
300 |
_a325-31 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 |
_aAngina Pectoris _xdrug therapy |
650 | 0 | 4 |
_aCalcium Channel Blockers _xadverse effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDiltiazem _xtherapeutic use |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aExercise Test _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNicardipine _xtherapeutic use |
650 | 0 | 4 |
_aNifedipine _xtherapeutic use |
650 | 0 | 4 |
_aNitroglycerin _xadministration & dosage |
650 | 0 | 4 |
_aPropranolol _xadverse effects |
650 | 0 | 4 | _aSingle-Blind Method |
650 | 0 | 4 |
_aVerapamil _xtherapeutic use |
700 | 1 | _aAzzollini, F | |
700 | 1 | _aCereda, A | |
700 | 1 | _aPelosi, G | |
773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 37 _gno. 4 _gp. 325-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00558494 _zAvailable from publisher's website |
999 |
_c2519200 _d2519200 |